Ceperognastat

DB21591InvestigationalSmall molecule

Ceperognastat is a small molecule drug. Ceperognastat is under investigation in clinical trial NCT05063539 (A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease).... Ceperognastat has a monoisotopic molecular weight of 383.14 Da.

Formula / weight: C₁₆H₂₂FN₅O₃S · 383.44 g/mol (avg)
Code names: LY-3372689

Resolves to

Compound

UNIIU0SGP6ZX2VCAS2241514-56-5ChEMBLCHEMBL5095251ChEBI758828PubChem135260636

Structure

InChIKeyFRVXHWNHGWUTQO-CABZTGNLSA-NSMILESC[C@H]1C[C@H](CCN1CC1=C(F)N=C(NC(C)=O)S1)OCC1=NOC(C)=N1

Targets

O60502OGA

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Ceperognastat, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account